Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000251659 | SCV000306251 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000680760 | SCV000808204 | benign | not provided | 2018-06-20 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
ARUP Laboratories, |
RCV000251659 | SCV001156648 | benign | not specified | 2018-09-14 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001782740 | SCV002026731 | benign | Neurofibromatosis, type 1 | 2021-09-05 | criteria provided, single submitter | clinical testing | |
KCCC/NGS Laboratory, |
RCV003316361 | SCV004016062 | benign | Neurofibromatosis, familial spinal | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV000680760 | SCV005253757 | benign | not provided | criteria provided, single submitter | not provided |